Benjaminj Hindson News Today

Eagle Asset Management Inc. trimmed its position in 10x Genomics, Inc. (NASDAQ:TXG – Free Report) by 0.8% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 729,476 shares of the company’s stock after selling 5,710 shares during the period. Eagle […]

10x Genomics (NASDAQ:TXG – Free Report) had its target price lowered by Canaccord Genuity Group from $65.00 to $50.00 in a report released on Monday, Benzinga reports. Canaccord Genuity Group currently has a buy rating on the stock. Several other equities analysts have also recently commented on TXG. Deutsche Bank Aktiengesellschaft decreased their price target […]

10x Genomics (NASDAQ:TXG – Free Report) had its price target reduced by The Goldman Sachs Group from $30.00 to $26.00 in a research report released on Wednesday, Benzinga reports. They currently have a sell rating on the stock. A number of other research firms also recently weighed in on TXG. TD Cowen downgraded shares of […]

10x Genomics (NASDAQ:TXG – Free Report) had its price objective lowered by Stifel Nicolaus from $63.00 to $53.00 in a research note released on Wednesday, Benzinga reports. Stifel Nicolaus currently has a buy rating on the stock. Several other research analysts also recently issued reports on TXG. TD Cowen downgraded 10x Genomics from a buy […]

10x Genomics (NASDAQ:TXG – Get Free Report) announced its quarterly earnings data on Tuesday. The company reported ($0.50) EPS for the quarter, meeting the consensus estimate of ($0.50), Yahoo Finance reports. 10x Genomics had a negative net margin of 42.20% and a negative return on equity of 30.43%. The company had revenue of $141.01 million […]

10x Genomics (NASDAQ:TXG – Get Free Report) announced its quarterly earnings data on Tuesday. The company reported ($0.50) EPS for the quarter, meeting the consensus estimate of ($0.50), Yahoo Finance reports. 10x Genomics had a negative net margin of 42.20% and a negative return on equity of 30.43%. The company had revenue of $141.01 million […]

10x Genomics (NASDAQ:TXG – Get Free Report) issued its quarterly earnings results on Tuesday. The company reported ($0.50) earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of ($0.50), Yahoo Finance reports. The business had revenue of $141.01 million for the quarter, compared to the consensus estimate of $142.24 million. 10x Genomics had […]

10x Genomics, Inc. (NASDAQ:TXG – Get Free Report) insider Benjamin J. Hindson sold 2,613 shares of the business’s stock in a transaction on Thursday, February 22nd. The stock was sold at an average price of $46.34, for a total value of $121,086.42. Following the completion of the transaction, the insider now directly owns 283,059 shares […]

10x Genomics, Inc. (NASDAQ:TXG – Get Free Report) insider Benjamin J. Hindson sold 2,613 shares of the firm’s stock in a transaction dated Thursday, February 22nd. The stock was sold at an average price of $46.34, for a total transaction of $121,086.42. Following the completion of the transaction, the insider now owns 283,059 shares in […]

Handelsbanken Fonder AB lifted its holdings in shares of 10x Genomics, Inc. (NASDAQ:TXG – Free Report) by 4.2% in the second quarter, Holdings Channel.com reports. The institutional investor owned 14,900 shares of the company’s stock after acquiring an additional 600 shares during the period. Handelsbanken Fonder AB’s holdings in 10x Genomics were worth $832,000 at […]